Fascinating angle you raise, ie: who in this administration is gaining from data mining the American people’s healthcare patient information?
Dangerous question to ask that could give someone who digs too deep, a bad case of Obola Chicago strain.
What fearless investigator would take this on?
Maybe Sharyl Attkisson.